Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Abstract Introduction The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In clinical practice gepants might be considered as a valid option to treat acute attacks in patients with migraine who are treated with mAbs....
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Adis, Springer Healthcare
2024-02-01
|
| Serie: | Neurology and Therapy |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1007/s40120-024-00586-w |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|